nodes	percent_of_prediction	percent_of_DWPC	metapath
Amifostine—ALPPL2—nephron—kidney cancer	0.1	0.291	CbGeAlD
Amifostine—ALPPL2—urine—kidney cancer	0.0806	0.234	CbGeAlD
Amifostine—ALPL—nephron tubule—kidney cancer	0.0245	0.0711	CbGeAlD
Amifostine—ALPPL2—nephron tubule—kidney cancer	0.0217	0.0629	CbGeAlD
Amifostine—ALPL—cortex of kidney—kidney cancer	0.021	0.0608	CbGeAlD
Amifostine—ENPP1—renal system—kidney cancer	0.0205	0.0593	CbGeAlD
Amifostine—ENPP1—kidney—kidney cancer	0.0198	0.0573	CbGeAlD
Amifostine—ALPPL2—renal system—kidney cancer	0.0197	0.0572	CbGeAlD
Amifostine—ALPPL2—kidney—kidney cancer	0.0191	0.0553	CbGeAlD
Amifostine—ALPPL2—gonad—kidney cancer	0.0177	0.0513	CbGeAlD
Amifostine—ALPL—Endochondral Ossification—BMP7—kidney cancer	0.0102	0.0665	CbGpPWpGaD
Amifostine—ENPP1—Endochondral Ossification—BMP7—kidney cancer	0.00871	0.0565	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—EEF2—kidney cancer	0.00657	0.0426	CbGpPWpGaD
Amifostine—ALPL—NOTCH1 regulation of human endothelial cell calcification—VEGFA—kidney cancer	0.00603	0.0391	CbGpPWpGaD
Amifostine—ALPL—Endochondral Ossification—IGF2—kidney cancer	0.00498	0.0323	CbGpPWpGaD
Amifostine—ALPL—Endochondral Ossification—IGF1R—kidney cancer	0.00481	0.0312	CbGpPWpGaD
Amifostine—ENPP1—Endochondral Ossification—IGF2—kidney cancer	0.00423	0.0275	CbGpPWpGaD
Amifostine—ENPP1—Endochondral Ossification—IGF1R—kidney cancer	0.00409	0.0266	CbGpPWpGaD
Amifostine—ENPP1—Defective AMN causes hereditary megaloblastic anemia 1—SLC2A1—kidney cancer	0.00408	0.0265	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—HIF1A—kidney cancer	0.00387	0.0251	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—EIF4EBP1—kidney cancer	0.00381	0.0248	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—EIF4EBP1—kidney cancer	0.00298	0.0194	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—EGR1—kidney cancer	0.00298	0.0193	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—TSC1—kidney cancer	0.00277	0.018	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—RAF1—kidney cancer	0.00267	0.0174	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—RELA—kidney cancer	0.00266	0.0173	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—SLC2A1—kidney cancer	0.00251	0.0163	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—JUN—kidney cancer	0.00233	0.0151	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—EGR1—kidney cancer	0.00233	0.0151	CbGpPWpGaD
Amifostine—ALPL—Endochondral Ossification—VEGFA—kidney cancer	0.00209	0.0136	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—TSC2—kidney cancer	0.00207	0.0134	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—IGF1R—kidney cancer	0.00197	0.0128	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—MAPK3—kidney cancer	0.00193	0.0125	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—MAPK1—kidney cancer	0.00183	0.0119	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—APC—kidney cancer	0.00182	0.0118	CbGpPWpGaD
Amifostine—ENPP1—Endochondral Ossification—VEGFA—kidney cancer	0.00178	0.0115	CbGpPWpGaD
Amifostine—ENPP1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—kidney cancer	0.00176	0.0114	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—TSC2—kidney cancer	0.00161	0.0105	CbGpPWpGaD
Amifostine—Ill-defined disorder—Vinblastine—kidney cancer	0.00156	0.0031	CcSEcCtD
Amifostine—Ill-defined disorder—Everolimus—kidney cancer	0.00155	0.00309	CcSEcCtD
Amifostine—Flushing—Sorafenib—kidney cancer	0.00155	0.00309	CcSEcCtD
Amifostine—Dyspnoea—Pazopanib—kidney cancer	0.00154	0.00307	CcSEcCtD
Amifostine—Somnolence—Pazopanib—kidney cancer	0.00154	0.00306	CcSEcCtD
Amifostine—Erythema multiforme—Sunitinib—kidney cancer	0.00152	0.00302	CcSEcCtD
Amifostine—Malaise—Vinblastine—kidney cancer	0.00151	0.00302	CcSEcCtD
Amifostine—ENPP1—Metabolism—ACY1—kidney cancer	0.00151	0.00981	CbGpPWpGaD
Amifostine—Malaise—Everolimus—kidney cancer	0.00151	0.00301	CcSEcCtD
Amifostine—Syncope—Everolimus—kidney cancer	0.0015	0.00299	CcSEcCtD
Amifostine—Acute coronary syndrome—Vincristine—kidney cancer	0.00149	0.00297	CcSEcCtD
Amifostine—Arrhythmia—Sorafenib—kidney cancer	0.00149	0.00297	CcSEcCtD
Amifostine—Flushing—Sunitinib—kidney cancer	0.00149	0.00297	CcSEcCtD
Amifostine—Myocardial infarction—Vincristine—kidney cancer	0.00148	0.00295	CcSEcCtD
Amifostine—Cardiac arrest—Paclitaxel—kidney cancer	0.00148	0.00295	CcSEcCtD
Amifostine—Loss of consciousness—Everolimus—kidney cancer	0.00147	0.00293	CcSEcCtD
Amifostine—Convulsion—Vinblastine—kidney cancer	0.00145	0.0029	CcSEcCtD
Amifostine—Body temperature increased—Temsirolimus—kidney cancer	0.00145	0.00289	CcSEcCtD
Amifostine—Hypertension—Vinblastine—kidney cancer	0.00145	0.00289	CcSEcCtD
Amifostine—Convulsion—Everolimus—kidney cancer	0.00145	0.00289	CcSEcCtD
Amifostine—Syncope—Erlotinib—kidney cancer	0.00145	0.00288	CcSEcCtD
Amifostine—Feeling hot—Doxorubicin—kidney cancer	0.00145	0.00288	CcSEcCtD
Amifostine—ENPP1—Disease—CCBL1—kidney cancer	0.00144	0.00937	CbGpPWpGaD
Amifostine—Hypertension—Everolimus—kidney cancer	0.00144	0.00288	CcSEcCtD
Amifostine—Chills—Sunitinib—kidney cancer	0.00144	0.00287	CcSEcCtD
Amifostine—Erythema multiforme—Dactinomycin—kidney cancer	0.00143	0.00286	CcSEcCtD
Amifostine—ALPL—BDNF signaling pathway—RAF1—kidney cancer	0.00143	0.0093	CbGpPWpGaD
Amifostine—Arrhythmia—Sunitinib—kidney cancer	0.00143	0.00286	CcSEcCtD
Amifostine—ALPL—BDNF signaling pathway—RELA—kidney cancer	0.00143	0.00926	CbGpPWpGaD
Amifostine—Chest pain—Everolimus—kidney cancer	0.00142	0.00284	CcSEcCtD
Amifostine—Stevens-Johnson syndrome—Gemcitabine—kidney cancer	0.00142	0.00283	CcSEcCtD
Amifostine—Loss of consciousness—Erlotinib—kidney cancer	0.00142	0.00283	CcSEcCtD
Amifostine—Acute coronary syndrome—Gemcitabine—kidney cancer	0.00141	0.00282	CcSEcCtD
Amifostine—Discomfort—Vinblastine—kidney cancer	0.00141	0.00281	CcSEcCtD
Amifostine—Renal failure—Gemcitabine—kidney cancer	0.00141	0.00281	CcSEcCtD
Amifostine—Flushing—Dactinomycin—kidney cancer	0.00141	0.00281	CcSEcCtD
Amifostine—Discomfort—Everolimus—kidney cancer	0.00141	0.0028	CcSEcCtD
Amifostine—Myocardial infarction—Gemcitabine—kidney cancer	0.0014	0.0028	CcSEcCtD
Amifostine—Toxic epidermal necrolysis—Paclitaxel—kidney cancer	0.0014	0.0028	CcSEcCtD
Amifostine—ALPL—BDNF signaling pathway—MTOR—kidney cancer	0.0014	0.00908	CbGpPWpGaD
Amifostine—Rigors—Doxorubicin—kidney cancer	0.00139	0.00277	CcSEcCtD
Amifostine—Chest pain—Erlotinib—kidney cancer	0.00137	0.00274	CcSEcCtD
Amifostine—Chills—Dactinomycin—kidney cancer	0.00136	0.00272	CcSEcCtD
Amifostine—Dermatitis exfoliative—Capecitabine—kidney cancer	0.00135	0.0027	CcSEcCtD
Amifostine—Hypersensitivity—Temsirolimus—kidney cancer	0.00135	0.00269	CcSEcCtD
Amifostine—Atrial fibrillation—Capecitabine—kidney cancer	0.00135	0.00269	CcSEcCtD
Amifostine—Shock—Everolimus—kidney cancer	0.00134	0.00268	CcSEcCtD
Amifostine—Tachycardia—Everolimus—kidney cancer	0.00133	0.00266	CcSEcCtD
Amifostine—ENPP1—Disease—AMER1—kidney cancer	0.0013	0.00847	CbGpPWpGaD
Amifostine—Syncope—Sorafenib—kidney cancer	0.0013	0.0026	CcSEcCtD
Amifostine—Pruritus—Temsirolimus—kidney cancer	0.0013	0.00259	CcSEcCtD
Amifostine—Shock—Erlotinib—kidney cancer	0.00129	0.00258	CcSEcCtD
Amifostine—ENPP1—Metabolism—PDHB—kidney cancer	0.00129	0.00834	CbGpPWpGaD
Amifostine—Loss of consciousness—Sorafenib—kidney cancer	0.00127	0.00254	CcSEcCtD
Amifostine—Hypotension—Everolimus—kidney cancer	0.00127	0.00254	CcSEcCtD
Amifostine—Hypertension—Sorafenib—kidney cancer	0.00125	0.0025	CcSEcCtD
Amifostine—ALPL—BDNF signaling pathway—JUN—kidney cancer	0.00125	0.00811	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—CTNNB1—kidney cancer	0.00124	0.00805	CbGpPWpGaD
Amifostine—Hypocalcaemia—Doxorubicin—kidney cancer	0.00124	0.00247	CcSEcCtD
Amifostine—Ill-defined disorder—Dactinomycin—kidney cancer	0.00123	0.00245	CcSEcCtD
Amifostine—Pruritus—Pazopanib—kidney cancer	0.00122	0.00244	CcSEcCtD
Amifostine—Erythema multiforme—Gemcitabine—kidney cancer	0.00122	0.00243	CcSEcCtD
Amifostine—Dyspnoea—Everolimus—kidney cancer	0.00122	0.00243	CcSEcCtD
Amifostine—Cardiac arrest—Capecitabine—kidney cancer	0.00121	0.00242	CcSEcCtD
Amifostine—Somnolence—Everolimus—kidney cancer	0.00121	0.00242	CcSEcCtD
Amifostine—Dizziness—Temsirolimus—kidney cancer	0.00121	0.00242	CcSEcCtD
Amifostine—Convulsion—Sunitinib—kidney cancer	0.00121	0.00241	CcSEcCtD
Amifostine—ENPP1—Metabolism—CCBL1—kidney cancer	0.00121	0.00784	CbGpPWpGaD
Amifostine—Hypertension—Sunitinib—kidney cancer	0.0012	0.0024	CcSEcCtD
Amifostine—Malaise—Dactinomycin—kidney cancer	0.00119	0.00238	CcSEcCtD
Amifostine—Stevens-Johnson syndrome—Paclitaxel—kidney cancer	0.00119	0.00237	CcSEcCtD
Amifostine—Chest pain—Sunitinib—kidney cancer	0.00119	0.00237	CcSEcCtD
Amifostine—Anaphylactic shock—Sorafenib—kidney cancer	0.00118	0.00236	CcSEcCtD
Amifostine—Acute coronary syndrome—Paclitaxel—kidney cancer	0.00118	0.00236	CcSEcCtD
Amifostine—Renal failure—Paclitaxel—kidney cancer	0.00118	0.00235	CcSEcCtD
Amifostine—Myocardial infarction—Paclitaxel—kidney cancer	0.00118	0.00235	CcSEcCtD
Amifostine—Dyspnoea—Erlotinib—kidney cancer	0.00117	0.00234	CcSEcCtD
Amifostine—Vomiting—Temsirolimus—kidney cancer	0.00117	0.00233	CcSEcCtD
Amifostine—Shock—Sorafenib—kidney cancer	0.00116	0.00232	CcSEcCtD
Amifostine—Rash—Temsirolimus—kidney cancer	0.00116	0.00231	CcSEcCtD
Amifostine—Dermatitis—Temsirolimus—kidney cancer	0.00115	0.0023	CcSEcCtD
Amifostine—Chills—Gemcitabine—kidney cancer	0.00115	0.0023	CcSEcCtD
Amifostine—Toxic epidermal necrolysis—Capecitabine—kidney cancer	0.00115	0.0023	CcSEcCtD
Amifostine—Arrhythmia—Gemcitabine—kidney cancer	0.00115	0.00229	CcSEcCtD
Amifostine—Dizziness—Pazopanib—kidney cancer	0.00114	0.00228	CcSEcCtD
Amifostine—Hiccups—Doxorubicin—kidney cancer	0.00113	0.00226	CcSEcCtD
Amifostine—Feeling abnormal—Vinblastine—kidney cancer	0.00113	0.00225	CcSEcCtD
Amifostine—Feeling abnormal—Everolimus—kidney cancer	0.00112	0.00224	CcSEcCtD
Amifostine—Shock—Sunitinib—kidney cancer	0.00112	0.00224	CcSEcCtD
Amifostine—ENPP1—Insulin Signaling—RAF1—kidney cancer	0.00112	0.00727	CbGpPWpGaD
Amifostine—Discomfort—Dactinomycin—kidney cancer	0.00111	0.00222	CcSEcCtD
Amifostine—Vomiting—Pazopanib—kidney cancer	0.0011	0.00219	CcSEcCtD
Amifostine—Bradycardia—Paclitaxel—kidney cancer	0.0011	0.00219	CcSEcCtD
Amifostine—ENPP1—Disease—GPC3—kidney cancer	0.00109	0.0071	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—MTOR—kidney cancer	0.00109	0.00709	CbGpPWpGaD
Amifostine—Rash—Pazopanib—kidney cancer	0.00109	0.00217	CcSEcCtD
Amifostine—Nausea—Temsirolimus—kidney cancer	0.00109	0.00217	CcSEcCtD
Amifostine—Dermatitis—Pazopanib—kidney cancer	0.00109	0.00217	CcSEcCtD
Amifostine—Body temperature increased—Everolimus—kidney cancer	0.00108	0.00215	CcSEcCtD
Amifostine—Dyspnoea—Sorafenib—kidney cancer	0.00106	0.00211	CcSEcCtD
Amifostine—ENPP1—Metabolism—PPAT—kidney cancer	0.00105	0.0068	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—GLIPR1—kidney cancer	0.00105	0.0068	CbGpPWpGaD
Amifostine—Body temperature increased—Erlotinib—kidney cancer	0.00104	0.00208	CcSEcCtD
Amifostine—Ill-defined disorder—Gemcitabine—kidney cancer	0.00104	0.00207	CcSEcCtD
Amifostine—ALPL—BDNF signaling pathway—MAPK3—kidney cancer	0.00103	0.0067	CbGpPWpGaD
Amifostine—Nausea—Pazopanib—kidney cancer	0.00103	0.00205	CcSEcCtD
Amifostine—Convulsion—Vincristine—kidney cancer	0.00102	0.00204	CcSEcCtD
Amifostine—Hypertension—Vincristine—kidney cancer	0.00102	0.00203	CcSEcCtD
Amifostine—Erythema multiforme—Paclitaxel—kidney cancer	0.00102	0.00203	CcSEcCtD
Amifostine—Dyspnoea—Sunitinib—kidney cancer	0.00102	0.00203	CcSEcCtD
Amifostine—ENPP1—Disease—ST3GAL2—kidney cancer	0.00101	0.00657	CbGpPWpGaD
Amifostine—Malaise—Gemcitabine—kidney cancer	0.00101	0.00201	CcSEcCtD
Amifostine—Hypersensitivity—Vinblastine—kidney cancer	0.00101	0.00201	CcSEcCtD
Amifostine—Hypersensitivity—Everolimus—kidney cancer	0.001	0.002	CcSEcCtD
Amifostine—Flushing—Paclitaxel—kidney cancer	0.000999	0.00199	CcSEcCtD
Amifostine—ALPL—BDNF signaling pathway—MAPK1—kidney cancer	0.000982	0.00638	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—JUN—kidney cancer	0.000976	0.00634	CbGpPWpGaD
Amifostine—Stevens-Johnson syndrome—Capecitabine—kidney cancer	0.000976	0.00195	CcSEcCtD
Amifostine—ENPP1—Metabolism—APRT—kidney cancer	0.000974	0.00632	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—FH—kidney cancer	0.000974	0.00632	CbGpPWpGaD
Amifostine—Acute coronary syndrome—Capecitabine—kidney cancer	0.00097	0.00194	CcSEcCtD
Amifostine—Renal failure—Capecitabine—kidney cancer	0.000968	0.00193	CcSEcCtD
Amifostine—Hypertension—Gemcitabine—kidney cancer	0.000967	0.00193	CcSEcCtD
Amifostine—Chills—Paclitaxel—kidney cancer	0.000966	0.00193	CcSEcCtD
Amifostine—Myocardial infarction—Capecitabine—kidney cancer	0.000965	0.00193	CcSEcCtD
Amifostine—Pruritus—Everolimus—kidney cancer	0.000965	0.00192	CcSEcCtD
Amifostine—Anaphylactic shock—Vincristine—kidney cancer	0.000963	0.00192	CcSEcCtD
Amifostine—Arrhythmia—Paclitaxel—kidney cancer	0.000962	0.00192	CcSEcCtD
Amifostine—Chest pain—Gemcitabine—kidney cancer	0.000953	0.0019	CcSEcCtD
Amifostine—ENPP1—Disease—PGK1—kidney cancer	0.000948	0.00616	CbGpPWpGaD
Amifostine—ENPP1—Disease—SLC5A3—kidney cancer	0.000948	0.00616	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—PTEN—kidney cancer	0.000944	0.00613	CbGpPWpGaD
Amifostine—Discomfort—Gemcitabine—kidney cancer	0.000942	0.00188	CcSEcCtD
Amifostine—Urticaria—Sorafenib—kidney cancer	0.00094	0.00188	CcSEcCtD
Amifostine—Body temperature increased—Sorafenib—kidney cancer	0.000936	0.00187	CcSEcCtD
Amifostine—Pruritus—Erlotinib—kidney cancer	0.000931	0.00186	CcSEcCtD
Amifostine—ENPP1—Disease—LDHB—kidney cancer	0.00093	0.00604	CbGpPWpGaD
Amifostine—ENPP1—Disease—SFRP2—kidney cancer	0.00093	0.00604	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—GPC3—kidney cancer	0.000916	0.00595	CbGpPWpGaD
Amifostine—Anaphylactic shock—Gemcitabine—kidney cancer	0.000914	0.00182	CcSEcCtD
Amifostine—Dizziness—Vinblastine—kidney cancer	0.000905	0.00181	CcSEcCtD
Amifostine—Dizziness—Everolimus—kidney cancer	0.000902	0.0018	CcSEcCtD
Amifostine—Body temperature increased—Sunitinib—kidney cancer	0.0009	0.0018	CcSEcCtD
Amifostine—Hypotension—Vincristine—kidney cancer	0.0009	0.0018	CcSEcCtD
Amifostine—Bradycardia—Capecitabine—kidney cancer	0.0009	0.0018	CcSEcCtD
Amifostine—ENPP1—Metabolism—CA2—kidney cancer	0.000891	0.00578	CbGpPWpGaD
Amifostine—Feeling abnormal—Dactinomycin—kidney cancer	0.000888	0.00177	CcSEcCtD
Amifostine—Dermatitis exfoliative—Doxorubicin—kidney cancer	0.000873	0.00174	CcSEcCtD
Amifostine—Hypersensitivity—Sorafenib—kidney cancer	0.000872	0.00174	CcSEcCtD
Amifostine—Vomiting—Vinblastine—kidney cancer	0.00087	0.00174	CcSEcCtD
Amifostine—Dizziness—Erlotinib—kidney cancer	0.00087	0.00174	CcSEcCtD
Amifostine—Ill-defined disorder—Paclitaxel—kidney cancer	0.00087	0.00174	CcSEcCtD
Amifostine—ENPP1—Metabolism—ALAD—kidney cancer	0.000868	0.00564	CbGpPWpGaD
Amifostine—ENPP1—Disease—TCEB2—kidney cancer	0.000867	0.00563	CbGpPWpGaD
Amifostine—ENPP1—Disease—TCEB1—kidney cancer	0.000867	0.00563	CbGpPWpGaD
Amifostine—Vomiting—Everolimus—kidney cancer	0.000867	0.00173	CcSEcCtD
Amifostine—Rash—Everolimus—kidney cancer	0.00086	0.00172	CcSEcCtD
Amifostine—Dermatitis—Everolimus—kidney cancer	0.000859	0.00171	CcSEcCtD
Amifostine—Hypotension—Gemcitabine—kidney cancer	0.000854	0.0017	CcSEcCtD
Amifostine—Body temperature increased—Dactinomycin—kidney cancer	0.000852	0.0017	CcSEcCtD
Amifostine—Anaphylactoid reaction—Doxorubicin—kidney cancer	0.000851	0.0017	CcSEcCtD
Amifostine—ENPP1—Metabolism—ST3GAL2—kidney cancer	0.000847	0.0055	CbGpPWpGaD
Amifostine—Malaise—Paclitaxel—kidney cancer	0.000845	0.00169	CcSEcCtD
Amifostine—Syncope—Paclitaxel—kidney cancer	0.000841	0.00168	CcSEcCtD
Amifostine—Hypersensitivity—Sunitinib—kidney cancer	0.000839	0.00167	CcSEcCtD
Amifostine—Pruritus—Sorafenib—kidney cancer	0.000837	0.00167	CcSEcCtD
Amifostine—Vomiting—Erlotinib—kidney cancer	0.000836	0.00167	CcSEcCtD
Amifostine—Erythema multiforme—Capecitabine—kidney cancer	0.000836	0.00167	CcSEcCtD
Amifostine—Rash—Erlotinib—kidney cancer	0.000829	0.00166	CcSEcCtD
Amifostine—Dermatitis—Erlotinib—kidney cancer	0.000829	0.00165	CcSEcCtD
Amifostine—ENPP1—Metabolism—ALDH1A1—kidney cancer	0.000828	0.00538	CbGpPWpGaD
Amifostine—Loss of consciousness—Paclitaxel—kidney cancer	0.000824	0.00164	CcSEcCtD
Amifostine—Flushing—Capecitabine—kidney cancer	0.00082	0.00164	CcSEcCtD
Amifostine—Dyspnoea—Gemcitabine—kidney cancer	0.000815	0.00163	CcSEcCtD
Amifostine—Nausea—Vinblastine—kidney cancer	0.000813	0.00162	CcSEcCtD
Amifostine—Somnolence—Gemcitabine—kidney cancer	0.000812	0.00162	CcSEcCtD
Amifostine—Convulsion—Paclitaxel—kidney cancer	0.000812	0.00162	CcSEcCtD
Amifostine—Nausea—Everolimus—kidney cancer	0.00081	0.00162	CcSEcCtD
Amifostine—Hypertension—Paclitaxel—kidney cancer	0.000809	0.00161	CcSEcCtD
Amifostine—ENPP1—Insulin Signaling—MAPK3—kidney cancer	0.000807	0.00524	CbGpPWpGaD
Amifostine—Pruritus—Sunitinib—kidney cancer	0.000806	0.00161	CcSEcCtD
Amifostine—Chest pain—Paclitaxel—kidney cancer	0.000798	0.00159	CcSEcCtD
Amifostine—Hypersensitivity—Dactinomycin—kidney cancer	0.000794	0.00159	CcSEcCtD
Amifostine—ENPP1—Metabolism—PGK1—kidney cancer	0.000794	0.00515	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—SLC5A3—kidney cancer	0.000794	0.00515	CbGpPWpGaD
Amifostine—Chills—Capecitabine—kidney cancer	0.000793	0.00158	CcSEcCtD
Amifostine—Arrhythmia—Capecitabine—kidney cancer	0.000789	0.00158	CcSEcCtD
Amifostine—Discomfort—Paclitaxel—kidney cancer	0.000788	0.00157	CcSEcCtD
Amifostine—Cardiac arrest—Doxorubicin—kidney cancer	0.000783	0.00156	CcSEcCtD
Amifostine—Dizziness—Sorafenib—kidney cancer	0.000783	0.00156	CcSEcCtD
Amifostine—Nausea—Erlotinib—kidney cancer	0.000781	0.00156	CcSEcCtD
Amifostine—ENPP1—Metabolism—LDHB—kidney cancer	0.000779	0.00506	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—MAPK1—kidney cancer	0.000768	0.00498	CbGpPWpGaD
Amifostine—Anaphylactic shock—Paclitaxel—kidney cancer	0.000765	0.00153	CcSEcCtD
Amifostine—Body temperature increased—Vincristine—kidney cancer	0.000761	0.00152	CcSEcCtD
Amifostine—Dizziness—Sunitinib—kidney cancer	0.000753	0.0015	CcSEcCtD
Amifostine—Feeling abnormal—Gemcitabine—kidney cancer	0.000753	0.0015	CcSEcCtD
Amifostine—Shock—Paclitaxel—kidney cancer	0.000753	0.0015	CcSEcCtD
Amifostine—Vomiting—Sorafenib—kidney cancer	0.000752	0.0015	CcSEcCtD
Amifostine—Tachycardia—Paclitaxel—kidney cancer	0.000747	0.00149	CcSEcCtD
Amifostine—Rash—Sorafenib—kidney cancer	0.000746	0.00149	CcSEcCtD
Amifostine—Dermatitis—Sorafenib—kidney cancer	0.000745	0.00149	CcSEcCtD
Amifostine—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	0.000741	0.00148	CcSEcCtD
Amifostine—Vomiting—Sunitinib—kidney cancer	0.000724	0.00144	CcSEcCtD
Amifostine—Body temperature increased—Gemcitabine—kidney cancer	0.000722	0.00144	CcSEcCtD
Amifostine—Rash—Sunitinib—kidney cancer	0.000718	0.00143	CcSEcCtD
Amifostine—Dermatitis—Sunitinib—kidney cancer	0.000717	0.00143	CcSEcCtD
Amifostine—Hypotension—Paclitaxel—kidney cancer	0.000715	0.00143	CcSEcCtD
Amifostine—Ill-defined disorder—Capecitabine—kidney cancer	0.000714	0.00142	CcSEcCtD
Amifostine—Hypersensitivity—Vincristine—kidney cancer	0.00071	0.00142	CcSEcCtD
Amifostine—ENPP1—Disease—RPL14—kidney cancer	0.000705	0.00457	CbGpPWpGaD
Amifostine—Nausea—Sorafenib—kidney cancer	0.000703	0.0014	CcSEcCtD
Amifostine—Malaise—Capecitabine—kidney cancer	0.000694	0.00138	CcSEcCtD
Amifostine—Syncope—Capecitabine—kidney cancer	0.00069	0.00138	CcSEcCtD
Amifostine—Vomiting—Dactinomycin—kidney cancer	0.000685	0.00137	CcSEcCtD
Amifostine—Dyspnoea—Paclitaxel—kidney cancer	0.000682	0.00136	CcSEcCtD
Amifostine—Somnolence—Paclitaxel—kidney cancer	0.00068	0.00136	CcSEcCtD
Amifostine—Rash—Dactinomycin—kidney cancer	0.00068	0.00136	CcSEcCtD
Amifostine—Nausea—Sunitinib—kidney cancer	0.000676	0.00135	CcSEcCtD
Amifostine—Loss of consciousness—Capecitabine—kidney cancer	0.000676	0.00135	CcSEcCtD
Amifostine—ENPP1—Metabolism—CA9—kidney cancer	0.000675	0.00438	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—PIK3CA—kidney cancer	0.000666	0.00432	CbGpPWpGaD
Amifostine—Hypertension—Capecitabine—kidney cancer	0.000664	0.00133	CcSEcCtD
Amifostine—Chest pain—Capecitabine—kidney cancer	0.000655	0.00131	CcSEcCtD
Amifostine—Discomfort—Capecitabine—kidney cancer	0.000647	0.00129	CcSEcCtD
Amifostine—Pruritus—Gemcitabine—kidney cancer	0.000646	0.00129	CcSEcCtD
Amifostine—Nausea—Dactinomycin—kidney cancer	0.00064	0.00128	CcSEcCtD
Amifostine—ENPP1—Disease—ITPR2—kidney cancer	0.000637	0.00414	CbGpPWpGaD
Amifostine—Dizziness—Vincristine—kidney cancer	0.000637	0.00127	CcSEcCtD
Amifostine—Feeling abnormal—Paclitaxel—kidney cancer	0.00063	0.00126	CcSEcCtD
Amifostine—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.000629	0.00126	CcSEcCtD
Amifostine—Renal failure—Doxorubicin—kidney cancer	0.000624	0.00124	CcSEcCtD
Amifostine—Shock—Capecitabine—kidney cancer	0.000618	0.00123	CcSEcCtD
Amifostine—Tachycardia—Capecitabine—kidney cancer	0.000613	0.00122	CcSEcCtD
Amifostine—Vomiting—Vincristine—kidney cancer	0.000612	0.00122	CcSEcCtD
Amifostine—Urticaria—Paclitaxel—kidney cancer	0.000608	0.00121	CcSEcCtD
Amifostine—Rash—Vincristine—kidney cancer	0.000607	0.00121	CcSEcCtD
Amifostine—Dermatitis—Vincristine—kidney cancer	0.000607	0.00121	CcSEcCtD
Amifostine—Body temperature increased—Paclitaxel—kidney cancer	0.000605	0.00121	CcSEcCtD
Amifostine—Hypotension—Capecitabine—kidney cancer	0.000587	0.00117	CcSEcCtD
Amifostine—Vomiting—Gemcitabine—kidney cancer	0.000581	0.00116	CcSEcCtD
Amifostine—Bradycardia—Doxorubicin—kidney cancer	0.00058	0.00116	CcSEcCtD
Amifostine—Rash—Gemcitabine—kidney cancer	0.000576	0.00115	CcSEcCtD
Amifostine—Dermatitis—Gemcitabine—kidney cancer	0.000576	0.00115	CcSEcCtD
Amifostine—ENPP1—Metabolism—CRABP1—kidney cancer	0.000574	0.00373	CbGpPWpGaD
Amifostine—Nausea—Vincristine—kidney cancer	0.000572	0.00114	CcSEcCtD
Amifostine—Hypersensitivity—Paclitaxel—kidney cancer	0.000564	0.00112	CcSEcCtD
Amifostine—Dyspnoea—Capecitabine—kidney cancer	0.00056	0.00112	CcSEcCtD
Amifostine—Nausea—Gemcitabine—kidney cancer	0.000543	0.00108	CcSEcCtD
Amifostine—Pruritus—Paclitaxel—kidney cancer	0.000541	0.00108	CcSEcCtD
Amifostine—Erythema multiforme—Doxorubicin—kidney cancer	0.000539	0.00107	CcSEcCtD
Amifostine—ENPP1—Disease—PSMD7—kidney cancer	0.000534	0.00347	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—ITPR2—kidney cancer	0.000534	0.00346	CbGpPWpGaD
Amifostine—Flushing—Doxorubicin—kidney cancer	0.000529	0.00105	CcSEcCtD
Amifostine—Feeling abnormal—Capecitabine—kidney cancer	0.000517	0.00103	CcSEcCtD
Amifostine—Chills—Doxorubicin—kidney cancer	0.000511	0.00102	CcSEcCtD
Amifostine—Arrhythmia—Doxorubicin—kidney cancer	0.000509	0.00102	CcSEcCtD
Amifostine—Dizziness—Paclitaxel—kidney cancer	0.000506	0.00101	CcSEcCtD
Amifostine—Urticaria—Capecitabine—kidney cancer	0.000499	0.000995	CcSEcCtD
Amifostine—Body temperature increased—Capecitabine—kidney cancer	0.000496	0.00099	CcSEcCtD
Amifostine—ENPP1—Metabolism—ACHE—kidney cancer	0.000487	0.00316	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—GSTT1—kidney cancer	0.000487	0.00316	CbGpPWpGaD
Amifostine—Vomiting—Paclitaxel—kidney cancer	0.000486	0.000971	CcSEcCtD
Amifostine—ENPP1—Disease—SLC2A1—kidney cancer	0.000483	0.00314	CbGpPWpGaD
Amifostine—Rash—Paclitaxel—kidney cancer	0.000482	0.000963	CcSEcCtD
Amifostine—Dermatitis—Paclitaxel—kidney cancer	0.000482	0.000962	CcSEcCtD
Amifostine—ENPP1—Disease—JUNB—kidney cancer	0.000479	0.00311	CbGpPWpGaD
Amifostine—Hypersensitivity—Capecitabine—kidney cancer	0.000463	0.000923	CcSEcCtD
Amifostine—ENPP1—Metabolism—SCARB1—kidney cancer	0.000461	0.00299	CbGpPWpGaD
Amifostine—Ill-defined disorder—Doxorubicin—kidney cancer	0.00046	0.000918	CcSEcCtD
Amifostine—ENPP1—Metabolism—PTGS1—kidney cancer	0.000456	0.00296	CbGpPWpGaD
Amifostine—Nausea—Paclitaxel—kidney cancer	0.000454	0.000907	CcSEcCtD
Amifostine—ENPP1—Metabolism—PSMD7—kidney cancer	0.000447	0.0029	CbGpPWpGaD
Amifostine—Malaise—Doxorubicin—kidney cancer	0.000447	0.000892	CcSEcCtD
Amifostine—Syncope—Doxorubicin—kidney cancer	0.000445	0.000887	CcSEcCtD
Amifostine—Pruritus—Capecitabine—kidney cancer	0.000444	0.000886	CcSEcCtD
Amifostine—Loss of consciousness—Doxorubicin—kidney cancer	0.000436	0.00087	CcSEcCtD
Amifostine—Convulsion—Doxorubicin—kidney cancer	0.00043	0.000857	CcSEcCtD
Amifostine—Hypertension—Doxorubicin—kidney cancer	0.000428	0.000854	CcSEcCtD
Amifostine—ENPP1—Metabolism—BCHE—kidney cancer	0.000424	0.00275	CbGpPWpGaD
Amifostine—Chest pain—Doxorubicin—kidney cancer	0.000422	0.000842	CcSEcCtD
Amifostine—ENPP1—Metabolism—SLC5A5—kidney cancer	0.000419	0.00272	CbGpPWpGaD
Amifostine—Discomfort—Doxorubicin—kidney cancer	0.000417	0.000832	CcSEcCtD
Amifostine—Dizziness—Capecitabine—kidney cancer	0.000415	0.000828	CcSEcCtD
Amifostine—Anaphylactic shock—Doxorubicin—kidney cancer	0.000405	0.000808	CcSEcCtD
Amifostine—ENPP1—Metabolism—SLC2A1—kidney cancer	0.000404	0.00263	CbGpPWpGaD
Amifostine—Vomiting—Capecitabine—kidney cancer	0.000399	0.000797	CcSEcCtD
Amifostine—Shock—Doxorubicin—kidney cancer	0.000398	0.000795	CcSEcCtD
Amifostine—Rash—Capecitabine—kidney cancer	0.000396	0.00079	CcSEcCtD
Amifostine—Dermatitis—Capecitabine—kidney cancer	0.000395	0.000789	CcSEcCtD
Amifostine—Tachycardia—Doxorubicin—kidney cancer	0.000395	0.000788	CcSEcCtD
Amifostine—ENPP1—Disease—CDKN2B—kidney cancer	0.00039	0.00253	CbGpPWpGaD
Amifostine—Hypotension—Doxorubicin—kidney cancer	0.000378	0.000755	CcSEcCtD
Amifostine—Nausea—Capecitabine—kidney cancer	0.000373	0.000744	CcSEcCtD
Amifostine—Dyspnoea—Doxorubicin—kidney cancer	0.000361	0.00072	CcSEcCtD
Amifostine—Somnolence—Doxorubicin—kidney cancer	0.00036	0.000718	CcSEcCtD
Amifostine—ENPP1—Metabolism—GSTP1—kidney cancer	0.000337	0.00219	CbGpPWpGaD
Amifostine—Feeling abnormal—Doxorubicin—kidney cancer	0.000333	0.000665	CcSEcCtD
Amifostine—Urticaria—Doxorubicin—kidney cancer	0.000321	0.000642	CcSEcCtD
Amifostine—Body temperature increased—Doxorubicin—kidney cancer	0.00032	0.000638	CcSEcCtD
Amifostine—ENPP1—Metabolism—ABCB1—kidney cancer	0.000319	0.00207	CbGpPWpGaD
Amifostine—ENPP1—Disease—HIF1A—kidney cancer	0.000312	0.00203	CbGpPWpGaD
Amifostine—ENPP1—Disease—TSC2—kidney cancer	0.000311	0.00202	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—GSTM1—kidney cancer	0.00031	0.00201	CbGpPWpGaD
Amifostine—Hypersensitivity—Doxorubicin—kidney cancer	0.000298	0.000595	CcSEcCtD
Amifostine—ENPP1—Metabolism—CYP1A1—kidney cancer	0.000294	0.00191	CbGpPWpGaD
Amifostine—Pruritus—Doxorubicin—kidney cancer	0.000286	0.000571	CcSEcCtD
Amifostine—ENPP1—Disease—APC—kidney cancer	0.000275	0.00178	CbGpPWpGaD
Amifostine—ENPP1—Disease—KIT—kidney cancer	0.000275	0.00178	CbGpPWpGaD
Amifostine—Dizziness—Doxorubicin—kidney cancer	0.000268	0.000534	CcSEcCtD
Amifostine—ENPP1—Disease—BRAF—kidney cancer	0.000258	0.00168	CbGpPWpGaD
Amifostine—Vomiting—Doxorubicin—kidney cancer	0.000257	0.000513	CcSEcCtD
Amifostine—Rash—Doxorubicin—kidney cancer	0.000255	0.000509	CcSEcCtD
Amifostine—Dermatitis—Doxorubicin—kidney cancer	0.000255	0.000509	CcSEcCtD
Amifostine—Nausea—Doxorubicin—kidney cancer	0.00024	0.00048	CcSEcCtD
Amifostine—ENPP1—Metabolism—POMC—kidney cancer	0.000219	0.00142	CbGpPWpGaD
Amifostine—ENPP1—Disease—RAF1—kidney cancer	0.000216	0.0014	CbGpPWpGaD
Amifostine—ENPP1—Disease—ERBB2—kidney cancer	0.000213	0.00139	CbGpPWpGaD
Amifostine—ENPP1—Disease—MTOR—kidney cancer	0.000211	0.00137	CbGpPWpGaD
Amifostine—ENPP1—Disease—CD4—kidney cancer	0.00021	0.00136	CbGpPWpGaD
Amifostine—ENPP1—Disease—PTGS2—kidney cancer	0.000209	0.00135	CbGpPWpGaD
Amifostine—ENPP1—Disease—CDKN1B—kidney cancer	0.000198	0.00128	CbGpPWpGaD
Amifostine—ENPP1—Disease—CTNNB1—kidney cancer	0.000187	0.00121	CbGpPWpGaD
Amifostine—ENPP1—Disease—PTEN—kidney cancer	0.000182	0.00118	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—PTGS2—kidney cancer	0.000175	0.00113	CbGpPWpGaD
Amifostine—ENPP1—Disease—MAPK3—kidney cancer	0.000155	0.00101	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—PTEN—kidney cancer	0.000152	0.000989	CbGpPWpGaD
Amifostine—ENPP1—Disease—MYC—kidney cancer	0.000151	0.000982	CbGpPWpGaD
Amifostine—ENPP1—Disease—MAPK1—kidney cancer	0.000148	0.000961	CbGpPWpGaD
Amifostine—ENPP1—Disease—KRAS—kidney cancer	0.00014	0.000907	CbGpPWpGaD
Amifostine—ENPP1—Disease—PIK3CA—kidney cancer	0.000128	0.000834	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—PIK3CA—kidney cancer	0.000108	0.000698	CbGpPWpGaD
